Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report.


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 20 4 2020
medline: 20 6 2020
entrez: 20 4 2020
Statut: ppublish

Résumé

The outbreak of 2019 novel coronavirus disease (COVID-19) began since early December 2019, and has been declared as a public health emergency by the World Health Organization. Due to the hypercoagulable state, blood stasis and endothelial injury, severe patients with COVID-19 are at high risk for thrombosis. We report a case of very severe COVID-19 complicated with venous thrombosis and arteriosclerosis obliterans of lower extremities. Risk stratification for deep vein thrombosis and peripheral arterial disease are of vital importance for the prognosis of COVID-19.

Identifiants

pubmed: 32306290
doi: 10.1007/s11239-020-02084-w
pii: 10.1007/s11239-020-02084-w
pmc: PMC7165253
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

229-232

Subventions

Organisme : the Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University, China
ID : No.XJTU1AF-CRF-2018-025

Références

Euro Surveill. 2020 Feb;25(5):
pubmed: 32019636
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Clin Med. 2020 Feb 11;9(2):
pubmed: 32054124
Emerg Infect Dis. 2020 May;26(5):1049-1052
pubmed: 32053479
Intensive Care Med. 2020 Feb;46(2):357-360
pubmed: 32025779
J Clin Virol. 2012 Jan;53(1):82-4
pubmed: 21978613
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
JAMA. 2014 Feb 19;311(7):717-28
pubmed: 24549552
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264

Auteurs

Bo Zhou (B)

Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. zb_bob@stu.xjtu.edu.cn.

Jianqing She (J)

Cardiology Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.

Yadan Wang (Y)

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. yadan_wang@hust.edu.com.

Xiancang Ma (X)

Department of Psychiatry, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. maxiancang@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH